For decades, the US has been at the forefront of promoting the global “war on drugs,” through the aggressive enforcement of criminal laws prohibiting the use, production, and distribution of illicit drugs. Yet increasingly, other countries and many in the US have been calling for a shift in approach, noting that the drug war has done little to address problematic drug use, while doing tremendous harm to health, human rights, and security. Many states have been experimenting with legalizing or decriminalizing marijuana, while other countries have already decriminalized the use and possession of all drugs.

Please join representatives from the Drug Policy Alliance and Human Rights Watch, along with two special guests from the Global Commission on Drug Policy–former Swiss President Ruth Dreifuss and Professor Michel Kazatchkine–for a conversation about the global movement toward decriminalization and prospects for drug reform under the new administration in Washington.
  • Ruth Dreifuss, Former President of Switzerland; Chair of the Global Commission on Drug Policy
  • Michel Kazatchkine, Professor of Medicine, Université René Descartes in Paris; Member of the Global Commission on Drug Policy
  • Ethan Nadelmann, Executive Director, Drug Policy Alliance
  • Maria McFarland Sánchez-MorenoCo-Director, US Program, Human RightsWatch
  • Jasmine Tyler (moderator), Senior Policy Advisor for Drug Policy and Global Health, Open Society Foundations

Sponsored by the Roosevelt House Public Policy Institute at Hunter College,
 the Hunter College Human Rights Program, Human Rights Watch, and the Drug Policy Alliance 

Drug Policy Reform Under the Trump Administration: Prospects for Change in the U.S. & Abroad | Posted on March 16th, 2017 | Human Rights Program Events